Cite
HARVARD Citation
Rudek, M. et al. (2014). A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus‐positive patients with cancer: AIDS Malignancy Consortium trial AMC 061. Cancer. 120 (8), pp. 1194-1202. [Online].